Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779686 · ClinicalTrials.gov registry record
PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration
A clinical trial, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- 32
- Enrollment target
NCT02779686 is a clinical trial that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 32 participants.
The verdict
NCT02779686 was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This study is being conducted to compare two different genetic tests developed to determine an individuals risk of developing serious vision threatening complications from age-related macular degeneration (ARMD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02779686
The ClinicalTrials.gov registry entry for NCT02779686 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02779686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02779686 about?
NCT02779686 is a clinical study titled "PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration". This study is being conducted to compare two different genetic tests developed to determine an individuals risk of developing serious vision threatening complications from age-related macular degeneration (ARMD).
What is the current status of trial NCT02779686?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2012-01. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT02779686?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.